![Michael David Testa](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael David Testa
Direktor/Vorstandsmitglied bei
Hemanext, Inc.
Profil
Michael David Testa is currently a Director at Hemanext, Inc. He previously worked as Vice Chairman & Vice President at T.
Rowe Price Group, Inc. and as Chief Investment Officer at T.
Rowe Price Associates, Inc. (Investment Management).
Aktive Positionen von Michael David Testa
| Unternehmen | Position | Beginn |
|---|---|---|
Hemanext, Inc.
 Hemanext, Inc. Medical SpecialtiesHealth Technology Develops anaerobic storage system that minimizes oxidative damage to red blood cells | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Michael David Testa
| Unternehmen | Position | Ende |
|---|---|---|
| T. ROWE PRICE GROUP, INC. | Direktor/Vorstandsmitglied | - |
T. Rowe Price Associates, Inc. (IM)
 T. Rowe Price Associates, Inc. (IM) Investment ManagersFinance Price Associates uses a complex and multifaceted approach to investment analysis and asset management decisions. They integrate ESG factors into their investment research process. The firm focuses on the ESG factors they consider most likely to have a material impact on the performance of securities in client accounts. Price Associates also focuses on their analytical process on three areas of research: the industry, the contracts issued, and the creditworthiness of each individual issuer. | Head-Equity Investments | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
9
Beziehungen ersten Grades
3
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
T. Rowe Price Associates, Inc. (IM)
T. Rowe Price Associates, Inc. (IM) Investment ManagersFinance Price Associates uses a complex and multifaceted approach to investment analysis and asset management decisions. They integrate ESG factors into their investment research process. The firm focuses on the ESG factors they consider most likely to have a material impact on the performance of securities in client accounts. Price Associates also focuses on their analytical process on three areas of research: the industry, the contracts issued, and the creditworthiness of each individual issuer. | Finance |
T. Rowe Price Group, Inc.
 T. Rowe Price Group, Inc. Investment ManagersFinance Functions as a financial services holding company through its subsidiaries provides investment advisory services | Finance |
Hemanext, Inc.
Hemanext, Inc. Medical SpecialtiesHealth Technology Develops anaerobic storage system that minimizes oxidative damage to red blood cells | Health Technology |
